|
ACTR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.357800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.325000E-01 |
| Normal-vs-Stage2 |
6.006400E-01 |
| Normal-vs-Stage3 |
8.485400E-01 |
| Normal-vs-Stage4 |
9.603000E-01 |
| Stage1-vs-Stage2 |
8.478200E-01 |
| Stage1-vs-Stage3 |
7.255200E-01 |
| Stage1-vs-Stage4 |
4.793000E-01 |
| Stage2-vs-Stage3 |
6.975400E-01 |
| Stage2-vs-Stage4 |
5.822400E-01 |
| Stage3-vs-Stage4 |
8.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.928200E-01 |
| Normal-vs-AfricanAmerican |
1.795920E-02 |
| Normal-vs-Asian |
5.390400E-01 |
| Caucasian-vs-AfricanAmerican |
1.246090E-04 |
| Caucasian-vs-Asian |
7.861800E-01 |
| AfricanAmerican-vs-Asian |
6.788400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.703200E-01 |
| Normal-vs-Female |
6.539600E-01 |
| Male-vs-Female |
9.341800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.868200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.797200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.253600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.098800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.021600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.565400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.132800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.494000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.270600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.322600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.186200E-01 |
| Normal-vs-Grade 2 |
2.705400E-01 |
| Normal-vs-Grade 3 |
8.132600E-01 |
| Normal-vs-Grade 4 |
8.169200E-01 |
| Grade 1-vs-Grade 2 |
9.468000E-01 |
| Grade 1-vs-Grade 3 |
4.118200E-01 |
| Grade 1-vs-Grade 4 |
5.771800E-01 |
| Grade 2-vs-Grade 3 |
8.606500E-02 |
| Grade 2-vs-Grade 4 |
5.004400E-01 |
| Grade 3-vs-Grade 4 |
6.367800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.456360E-01 |
| Normal-vs-ccB subtype |
5.344600E-01 |
| ccA subtype-vs-ccB subtype |
3.357600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.069600E-01 |
| Normal-vs-N1 |
3.832000E-01 |
| N0-vs-N1 |
4.600200E-01 |
|
|
